enemyofpluto, I don't think our share price being held back is due to the hit pieces of the past albeit it does somewhat linger in the minds of those that read it and those that see the slow, crawling direction CYDY is moving in but in actuality, Vyrologix can/might be the only one with a LH trial with a real true immunomodulation of the C-storm so, yes, I do agree we should be around 4-5/share especially now that we might have good results from the 2nd intermim of p3. Who knows, the book hasn't been written for this molecule yet for only the nose knows for sure - GLTU

HCIT